Introducing the new AltIndexLearn more
$232.9413.5%upside
Price 6 Months Forecast & Ratings · Updated Aug 8, 2026
78/100 AI Score
Buy
Brand
0/100
Employment
79/100
User Growth
79/100
Fundamental
38/100
Get RVMD AI Score alerts →

Revolution Medicines (RVMD) Price Target: AI vs Analyst Consensus

Our AI model gives Revolution Medicines (RVMD) a 6-month price target of $232.94, representing 13.5% potential upside from the current price of $205.15. The forecast combines financial fundamentals, technical analysis, and 25+ alternative data signals, including hiring trends, web traffic, employee sentiment, and social media activity. Revolution Medicines’s current AI Score is 78/100 (Buy).

What’s Driving the RVMD Price Target

These are the signals feeding Revolution Medicines’s AI price target — spanning financial fundamentals, technical analysis, and alternative data — grouped by their recent direction. Improving signals tend to support a higher target; declining signals weigh on it.

RVMD Stock Forecast for 2026

Our AI model gives Revolution Medicines (RVMD) a 6-month price target of $232.94 — 13.5% upside from the current price of $205.15 — implying a climb toward that level through the rest of 2026. The target updates daily as new RVMD financial, technical, and alternative-data signals come in.

RVMD Price Prediction for 2027–2030

AltIndex does not publish a multi-year model — alternative data is most predictive over the next 6–12 months. Extending the current trajectory as a simple linear extrapolation projects RVMD toward $395.05 by 2030, but long-range estimates carry far more uncertainty and should be treated as directional only. The more reliable signal is whether Revolution Medicines’s AI Score and the drivers above keep improving over time.

Revolution Medicines (RVMD) Monthly Price Forecast

MonthForecastvs Current
Sep 2026 $209.78 +2.3%
Oct 2026 $214.41 +4.5%
Nov 2026 $219.05 +6.8%
Dec 2026 $223.68 +9%
Jan 2027 $228.31 +11.3%
Feb 2027 $232.94 +13.5%

Straight-line projection from the latest price ($205.15) toward our 6-month AI target of $232.94. An estimate, not a month-by-month model.

See how AltIndex’s AI Score picks have performed →

Frequently Asked Questions: Revolution Medicines Price Prediction

On August 5, Revolution Medicines (RVMD) was assigned a Buy signal with a target price of $230.66. This signal was predicated on several factors, including a month-over-month spike in job posts, an encouraging high business outlook across the company's employees, an encouraging high sentiment across popular stock forums, and a month-over-month spike in web traffic.
The conviction in the pick is medium-low due to the fairly restrained amount of alternative data available.

Based on Alternative Data, Revolution Medicines is a buy.

Based on the data provided, it's advisable to consider buying Revolution Medicines (RVMD) stock. The observed positive trends all contribute to a buy signal. However, this information should not be considered financial advice. Like any investment choice, it's important to conduct comprehensive research, not only utilizing alternative data, but also considering the company's financials, industry trends, and recent news developments.

With an AI score of 78, the RVMD stock forecast indicates a positive outlook.

To predict the price for RVMD in 2027, we can extrapolate the AI price target. This approach projects RVMD's price to reach $228.31.

To predict the price for RVMD in 2030, we can again extrapolate the AI price target. This approach projects RVMD's price to reach $395.05.

When predicting the price for RVMD, our approach incorporates multiple scores assessing different aspects of the company. The Brand score measures growth and engagement across social media channels, indicating audience reach. The Employee score evaluates workforce health, considering job postings, business outlook, and employee ratings. The Customer score examines engagement on websites, app downloads, and sentiment in stock forums. Lastly, the Fundamental score analyzes financial statements and analyst ratings. By evaluating this data, we gain a holistic view of the company's performance, enabling more informed price predictions.

Based on technical analysis of how the price has moved over the last 6 months, the likelihood of the price going up tomorrow is 38%. Note that this is a simplistic analysis and should be used with caution, as prices are influenced by a myriad of factors.

Know the moment Revolution Medicines’s price target changes

Get RVMD alerts
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.